Saul N Faust Selected Research

ChAdOx1 nCoV-19

11/2022	Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
12/2021	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
11/2021	AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific TH1 response with a diverse TCR repertoire.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
7/2021	T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.
1/2021	Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
1/2021	Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
1/2020	Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saul N Faust Research Topics

Disease

28	Infections 01/2022 - 10/2011
15	COVID-19 11/2022 - 01/2020
9	Malaria 11/2021 - 12/2012
7	Sepsis (Septicemia) 01/2020 - 08/2004
7	Human Influenza (Influenza) 01/2020 - 12/2010
6	Pneumococcal Infections 01/2017 - 10/2011
5	Fever (Fevers) 11/2022 - 10/2011
5	Pain (Aches) 11/2022 - 12/2014
5	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2016
5	Pneumonia (Pneumonitis) 11/2021 - 01/2017
5	Whooping Cough (Pertussis) 01/2020 - 12/2010
4	Inflammation (Inflammations) 02/2021 - 09/2006
4	Persistent Infection 12/2020 - 01/2017
4	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 12/2015
4	Diphtheria 01/2020 - 10/2011
4	Bites and Stings (Sting) 01/2018 - 12/2012
3	Meningococcal Infections 12/2022 - 07/2010
3	Virus Diseases (Viral Diseases) 01/2022 - 12/2015
3	Cough 11/2021 - 01/2021
3	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2014
3	Tetanus 01/2020 - 02/2015
3	Pseudomonas Infections 01/2017 - 12/2015
2	COVID-19 related pediatric multisystem inflammatory disease 01/2022 - 01/2021
2	Headache (Headaches) 12/2021 - 01/2020
2	Parasitemia 11/2021 - 06/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021 - 12/2015
2	Anosmia 10/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Communicable Diseases (Infectious Diseases) 04/2020 - 01/2019
2	Poliomyelitis (Polio) 01/2018 - 02/2015
2	Osteomyelitis 01/2017 - 06/2008
2	Lymphopenia (Lymphocytopenia) 01/2017 - 11/2016
1	Fatigue 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Neoplasms (Cancer) 01/2022
1	Oral Candidiasis (Thrush) 11/2021
1	Hepatitis B 10/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2021
1	Respiratory Insufficiency (Respiratory Failure) 02/2021
1	Lung Injury 02/2021
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021
1	Enterocolitis 01/2021

Drug/Important Bio-Agent (IBA)

38	VaccinesIBA 02/2022 - 12/2010
17	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2008
8	Conjugate VaccinesIBA 12/2022 - 10/2011
8	ChAdOx1 nCoV-19IBA 11/2022 - 01/2020
8	AntigensIBA 01/2022 - 12/2010
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2015
5	Amoxicillin (Wymox)FDA LinkGeneric 11/2021 - 01/2017
5	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 11/2021 - 04/2015
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020 - 03/2014
5	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 03/2012
3	MenACWYIBA 12/2022 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Nucleic AcidsIBA 10/2021 - 01/2021
3	ProdrugsIBA 01/2020 - 01/2017
3	CytokinesIBA 10/2017 - 02/2012
3	AntibodiesIBA 09/2016 - 07/2012
2	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 02/2022 - 08/2016
2	Methylprednisolone FDA LinkGeneric 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2021
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2010
2	Infliximab (Remicade)FDA Link 01/2021 - 10/2017
2	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2020 - 01/2020
2	ThrombospondinsIBA 01/2018 - 09/2016
2	Complement System Proteins (Complement)IBA 01/2018 - 07/2010
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2017 - 01/2017
2	Malaria VaccinesIBA 09/2016 - 12/2012
2	Combined VaccinesIBA 02/2015 - 01/2015
1	serogroup C meningococcal conjugate vaccineIBA 12/2022
1	Lipid NanoparticlesIBA 02/2022
1	mRNA VaccinesIBA 02/2022
1	C-Reactive ProteinIBA 01/2022
1	ProcalcitoninIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Pharmaceutical PreparationsIBA 11/2021
1	Anti-Idiotypic AntibodiesIBA 10/2021
1	GlucocorticoidsIBA 02/2021
1	Oxygen (Dioxygen)IBA 02/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2021
1	AntioxidantsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2021 - 06/2012
2	Length of Stay 01/2022 - 01/2016
2	Resuscitation 01/2020 - 01/2020
2	Surgical Amputation (Amputations) 01/2017 - 08/2004
2	Critical Care (Surgical Intensive Care) 01/2017 - 08/2016
1	Duration of Therapy 11/2021
1	Artificial Respiration (Mechanical Ventilation) 02/2021
1	Biological Therapy 01/2021